April 6 (Reuters) - Raptor Pharmaceutical Corp, which develops drugs that treat orphan diseases, is in discussions with investment banks to hire a financial adviser to explore a potential sale, according to people familiar with the matter.
The move may not lead to a sale, the people said this week, asking not to be identified because the deliberations are confidential. Raptor did not respond to a request for comment. (Reporting by Carl O’Donnell in New York; Editing by Leslie Adler)
Our Standards: The Thomson Reuters Trust Principles.